GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Encision Inc (OTCPK:ECIA) » Definitions » 3-Year EPS without NRI Growth Rate

Encision (Encision) 3-Year EPS without NRI Growth Rate : -14.50% (As of Dec. 2023)


View and export this data going back to 1996. Start your Free Trial

What is Encision 3-Year EPS without NRI Growth Rate?

Encision's EPS without NRI for the three months ended in Dec. 2023 was $-0.02.

During the past 3 years, the average EPS without NRI Growth Rate was -14.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Encision was 53.50% per year. The lowest was -40.90% per year. And the median was 29.50% per year.


Competitive Comparison of Encision's 3-Year EPS without NRI Growth Rate

For the Medical Instruments & Supplies subindustry, Encision's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Encision's 3-Year EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Encision's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Encision's 3-Year EPS without NRI Growth Rate falls into.



Encision 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Encision  (OTCPK:ECIA) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Encision 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Encision's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Encision (Encision) Business Description

Traded in Other Exchanges
N/A
Address
6797 Winchester Circle, Boulder, CO, USA, 80301
Encision Inc is a medical device company. The company develops and markets technology that provides unprecedented outcomes and patient safety in minimally-invasive surgery. The company has established and developed AEM (Active Electrode Monitoring) technology and surgical instruments which provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures while preventing stray electrosurgical energy that can cause complications and even death. The segments of the company are Product and Service. Product designs develops, manufactures and markets patented surgical instruments. Service performs electrical engineering activities for external entities.
Executives
Robert H Fries director 800 FILLMORE ST, DENVER CO 80206
Peter D Geary officer: VP of Operations 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Jason E Johnson officer: VP Sales 17752 WEDGEWOOD LANE, PRIOR LAKE MN 55372
Patrick R Dixon director 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Gregory J. Trudel director, officer: CEO 5241 RIMROCK LANE, FORT COLLINS CO 80526
Brian J Jackman director 6797 WINCHESTER CIRCLE, SUITE 100, BOULDER CO 80301
Von Der Lippe Paul director 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Denise Baker director 6797 WINCHESTER CIRCLE, BOULDER X1 80301
Vern D Kornelsen director, 10 percent owner 4605 S. DENICE DR, ENGLEWOOD CO 80111
Partners Lllp Cmed 10 percent owner
Patrick W Pace director 3701 SOARING EAGLE, AUSTIN TX 78746
Michael Biggs officer: VP Engineering 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Brad Greathouse officer: VP RA/QA 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Valerie Ray officer: VP of Operations 6797 WINCHESTER CIRCLE, BOULDER CO 80301
David W Newton director, officer: VP Technology 8099 NORTH 63RD STREET, LONGMONT CO 80503

Encision (Encision) Headlines

From GuruFocus

Encision Receives PPP Financing

By PRNewswire PRNewswire 04-23-2020

Encision Signs Supplier Agreement with Human Xtensions

By ACCESSWIRE ACCESSWIRE 02-28-2023

Encision Reports Second Quarter Fiscal Year 2021 Results

By PRNewswire PRNewswire 11-05-2020

Encision Reports Third Quarter Fiscal Year 2020 Results

By PRNewswire PRNewswire 02-06-2020

Encision Reports First Quarter Fiscal Year 2022 Results

By PRNewswire PRNewswire 08-09-2021

Encision Reports Second Quarter Fiscal Year 2019 Results

By PRNewswire PRNewswire 11-06-2018

Encision Reports Third Quarter Fiscal Year 2019 Results

By PRNewswire PRNewswire 02-07-2019

Encision Reports Second Quarter Fiscal Year 2022 Results

By PRNewswire PRNewswire 11-10-2021